US agencies shrink layoff plans after mass staff exodus
"Several agencies are now not planning to proceed" with staff cuts, Office of Personnel Management senior adviser Noah Peters said in a statement filed in federal court.
He said the financial incentives that departments offered employees to quit in the first few months of the administration, along with "natural attrition" were the reasons agencies were rethinking layoffs.
Peters did not specify which departments were reducing their planned layoffs.
This is the latest example of the Trump administration walking back announcements to cut federal workers, after more aggressively pursuing staff reductions earlier this year. The Department of Veterans Affairs said in July that it would reduce staff by about 30,000 people rather than 80,000.
Upon taking office in January, President Donald Trump launched a campaign to overhaul the 2.3 million-strong federal civilian workforce, led by billionaire Elon Musk and his Department of Government Efficiency. By late April, about 100 days into the effort, the government overhaul had resulted in the firing, resignations and early retirements of 260,000 civil servants, according to a Reuters tally.
As part of the overhaul, Trump in February ordered agencies to write blueprints for mass layoffs. Federal worker unions and their allies sued, arguing that the president needed permission from Congress to reshape the agencies. San Francisco-based U.S. District Judge Susan Illston in May sided with the unions and ordered the Trump administration not to carry out the plans while the case proceeded.
The Supreme Court on July 9 reversed Illston's order. The justices cleared the way for 19 federal agencies to pursue mass government job cuts. The list includes the departments of Defense and Homeland Security, among others.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mirror
27 minutes ago
- Daily Mirror
Donald Trump's two-word verdict on what will happen if Putin doesn't sign deal
Donald Trump spoke to reporters on the White House South Lawn after imposing a 50-day ultimatum on Vladimir Putin - and explained what would happen if it is not met Donald Trump has said it will be 'too bad' if Vladimir Putin does not agree to a ceasefire in Ukraine in a blasé ultimatum. The US president spoke to reporters on the White House South Lawn on Tuesday afternoon, the day after he threatened to impose "secondary tariffs" of up to 100% on Moscow if they fail to sign a deal within the next 50 days. Despite his infamous bust-up with Zelensky in the Oval Office in the first few weeks of his second term, Trump has in recent days signalled a surprising change in his position on the war, with his country now set to send a cache of"top-of-the-line" Patriot missiles to Kyiv via its allies in Europe. He's also appeared to toughen his rhetoric on the Russian president, claiming earlier this week that he was "disappointed" in Putin. On Tuesday, he repeated his threat to impose tariffs on sanctions on Russia if they fail to meet the 50-day ultimatum. Asked by one reporter what he repercussions would be for Moscow if they do not come to an agreement with Ukraine, Trump said: "Well at the end of 50 days if we don't have a deal, it's going to be too bad." "The tariffs are going to go on and other sanctions going to go on," he added when asked what the future of Russian relations looked like if Putin did not agree to end his war. He was also pressed on whether he had now switched sympathies in favour of Ukraine, after previously appearing reluctant to criticise Russia, and replied: "No, I'm on nobodies side. "You know whose side I'm on? Humanity's side, I want to stop the killing of thousands of people a week. I want to stop the killing. I want the killing to stop in the Ukraine-Russia war, that's the side I'm on." The President went on to say: 'We're going to see what happens with President Putin. So far I've been very disappointed with President Putin. I've solved a lot of wars in the last three months, but I haven't got this one yet. This is a Biden war, it's not a Trump war, I'm here to try and get us out of that mess.' But Trump appeared to downplay reports that he could soon supply Ukraine with more long-range weaponry, allowing it to strike directly on Moscow. Some in Ukraine and the US have said the move could help push Putin towards negotiations to end the fighting. Asked if he intended to supply Ukraine with weapons that could reach deeper into Russian territory, Trump replied: "We're not looking to do that." Trump made the remarks to reporters before departing the White House for an energy investment event in Pittsburgh.
Reuters
29 minutes ago
- Reuters
Hims & Hers hit with investor lawsuits after Novo ends Wegovy partnership
July 15 (Reuters) - Telehealth company Hims & Hers (HIMS.N), opens new tab is facing a growing number of U.S. investor lawsuits after Novo Nordisk's ( opens new tab decision last month to end a short-lived partnership to sell its Wegovy weight-loss drug through the platform sent shares plunging. A group of shareholders sued Hims on Monday in federal court in San Francisco, accusing its board and senior executives of making false and misleading statements about its financial condition and operations. The case was filed as a so-called derivative lawsuit on behalf of the company. The lawsuit follows two securities class actions filed by Hims investors in the same court last month, seeking damages over the drop in stock price after Novo in late June ended what the companies had initially described as a long-term collaboration designed to make obesity care and treatment more affordable and accessible. Hims, Novo and the lawyers who filed Monday's lawsuit did not immediately respond to requests for comment. Danish drugmaker Novo is not a defendant in the lawsuits. Founded in 2017, San Francisco-based Hims provides health and wellness products focused on weight loss, sexual and mental health and hair loss. Novo on June 23 said it was ending their partnership that began in late April, citing Hims' alleged improper marketing and sales of Wegovy copies. Novo accused Hims of 'deceptive promotion and selling of illegitimate, knockoff versions of Wegovy that put patient safety at risk.' Hims CEO Andrew Dudum responded, opens new tab in a post on X that day that accused Novo management of misleading the public and making anticompetitive demands 'that infringe on the independent decision making of providers and limit patient choice.' Hims shares fell $22.24, or over 34%, after Novo's announcement, declining from $64.22 per share on June 20 to close at $41.98 per share on June 23. The stock closed on Monday at $52.03 a share. The tight supply of Wegovy in the United States had allowed Hims and others to sell cheaper, compounded versions of the drug, known chemically as semaglutide. The U.S. Food and Drug Administration in February removed Wegovy from the agency's shortage list. Hims said the decision meant it could not guarantee continued sales of compounded semaglutide. The case is Steve Jones v. Andrew Dudum, U.S. District Court, Northern District of California, No. 3:25-cv-05866-AGT. For plaintiff: Shane Rowley of Rowley Law PLLC, and Francis "Casey" Flynn Jr. of Law Office of Francis J. Flynn Jr For defendants: No appearances yet Read more: Novo, Hims & Hers engage in war of words after Wegovy deal falls apart US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list Novo Nordisk to sell Wegovy through telehealth firms to cash-paying US customers
The Independent
31 minutes ago
- The Independent
The View host tears into Republican infighting over Epstein files
The View host Ana Navarro tore into Republicans' responses to the Trump administration's handling of the Epstein files during Tuesday's (15 July) program. It comes as a growing number of the president's supporters have complained after he encouraged people to move on from the Epstein files. For years, right-wing influencers circulated theories online about the government's investigation into Jeffrey Epstein and his death in federal prison, perpetuating claims that a ring of high-profile, powerful individuals helped cover up the convicted pedophile's actions and ensure he never stood trial. But last week's Justice Department and FBI memo shut down many of those theories, including the existence of a 'client list,' and disappointed many Trump supporters who refused to believe the absence of bombshell revelations. "It turns out that when you spend years building a five-alarm fire, you can't put it out by pissing on it," Ms Navarro said.
